Who are sevoflurane in step up concentration's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Suprane (desflurane), Baxter, Sevoflurane/Ultane, original sevoflurane, Volatile anesthetic, Isoflurane, Sevoflurane or Desflurane, Sevoflurane Inhalation Liquid.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/sevoflurane-in-step-up-concentration.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

sevoflurane in step up concentration — Competitive Intelligence Brief

sevoflurane in step up concentration (sevoflurane in step up concentration) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Volatile general anesthetic. Area: Anesthesiology.

marketed Volatile general anesthetic GABA-A receptor, NMDA receptor Anesthesiology Small molecule Live · refreshed every 30 min

Target snapshot

sevoflurane in step up concentration (sevoflurane in step up concentration) — University Hospital, Ghent. Sevoflurane is a volatile anesthetic that enhances inhibitory neurotransmission and suppresses excitatory signaling in the central nervous system to produce anesthesia.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
sevoflurane in step up concentration TARGET	sevoflurane in step up concentration	University Hospital, Ghent	marketed	Volatile general anesthetic	GABA-A receptor, NMDA receptor
Suprane (desflurane), Baxter	Suprane (desflurane), Baxter	Medical University of Gdansk	marketed	Volatile anesthetic	GABA-A receptor, NMDA receptor
Sevoflurane/Ultane	Sevoflurane/Ultane	Kaohsiung Medical University Chung-Ho Memorial Hospital	marketed	Volatile general anesthetic	GABA-A receptor, NMDA receptor
original sevoflurane	original sevoflurane	Asan Medical Center	marketed	Volatile anesthetic	GABA-A receptor, NMDA receptor
Volatile anesthetic	Volatile anesthetic	London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's	marketed	Volatile anesthetic	GABA-A receptor, NMDA receptor
Isoflurane, Sevoflurane or Desflurane	Isoflurane, Sevoflurane or Desflurane	King's College Hospital NHS Trust	marketed	Volatile anesthetic	GABA-A receptor, NMDA receptor
Sevoflurane Inhalation Liquid	Sevoflurane Inhalation Liquid	Damanhour Teaching Hospital	marketed	Volatile general anesthetic	GABA-A receptor, NMDA receptor

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Volatile general anesthetic class)

Damanhour Teaching Hospital · 1 drug in this class
Kaohsiung Medical University Chung-Ho Memorial Hospital · 1 drug in this class
University Hospital, Ghent · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). sevoflurane in step up concentration — Competitive Intelligence Brief. https://druglandscape.com/ci/sevoflurane-in-step-up-concentration. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab